Vir Biotechnology, Inc.

VIRNASDAQHealthcareBiotechnology

$11.04- (-)1Y +80.45%

As of Oct 26, 2026 close

Market cap: $1.86B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $4.82$12.00
Volume (live): -
Avg. volume (3M): 2.07M

Vir Biotechnology, Inc. (VIR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Vir Biotechnology, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy

Based on 8 unique analysts

(13 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$21.29

+92.84% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest VIR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 19, 2026	Etzer Darout	Barclays	Maintains	Buy	$30.00
Oct 14, 2026	Patrick Trucchio	HC Wainwright	Reiterates	Buy	$22.00
Oct 8, 2026	Etzer Darout	Barclays	Maintains	Buy	$30.00
Oct 7, 2026	Patrick Trucchio	HC Wainwright	Reiterates	Buy	$20.00 → $22.00 +2.00 (+10.0%)
Sep 30, 2026	Roanna Ruiz	Leerink Partners	Reiterates	Buy	$17.00
Sep 28, 2026	Joseph Stringer	Needham	Maintains	Buy	$18.00
Sep 21, 2026	Patrick Trucchio	HC Wainwright	Maintains	Buy	$20.00
Aug 7, 2026	Alec Stranahan	BofA Securities	Reiterates	Buy	$16.00 → $15.00 −1.00 (−6.3%)
Aug 6, 2026	Phil Nadeau	TD Cowen	Maintains	Buy	-
Aug 6, 2026	Etzer Darout	Barclays	Maintains	Buy	$30.00
Aug 6, 2026	Cory Kasimov	Evercore ISI Group	Maintains	Buy	$22.00
Aug 6, 2026	Michael Ulz	Morgan Stanley	Reiterates	Buy	$27.00 → $25.00 −2.00 (−7.4%)
Aug 5, 2026	Phil Nadeau	TD Cowen	Maintains	Buy	-

Etzer Darout

Barclays

BuyMaintains

$30.00

Oct 19

Patrick Trucchio

HC Wainwright

BuyReiterates

$22.00

Oct 14

Etzer Darout

Barclays

BuyMaintains

$30.00

Oct 8

Patrick Trucchio

HC Wainwright

BuyReiterates

$20.00 → $22.00

Oct 7

Roanna Ruiz

Leerink Partners

BuyReiterates

$17.00

Sep 30

Joseph Stringer

Needham

BuyMaintains

$18.00

Sep 28

Patrick Trucchio

HC Wainwright

BuyMaintains

$20.00

Sep 21

Alec Stranahan

BofA Securities

BuyReiterates

$16.00 → $15.00

Aug 7

Phil Nadeau

TD Cowen

BuyMaintains

Aug 6

Etzer Darout

Barclays

BuyMaintains

$30.00

Aug 6

Cory Kasimov

Evercore ISI Group

BuyMaintains

$22.00

Aug 6

Michael Ulz

Morgan Stanley

BuyReiterates

$27.00 → $25.00

Aug 6

Phil Nadeau

TD Cowen

BuyMaintains

Aug 5

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 19, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for VIR?

The analyst consensus rating for VIR is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for VIR?

The average 12-month price target for VIR is $21.29, representing an upside of 92.8% from the Oct 26, 2026 close of $11.04.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.